MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators

Biochemical and Biophysical Research Communications

Volumn 411, Issue 4, 2011, Pages 826-831

  Takata, Akemi ^a   Otsuka, Motoyuki ^a   Kojima, Kentaro ^a   Yoshikawa, Takeshi ^a   Kishikawa, Takahiro ^a   Yoshida, Haruhiko ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

MicroRNA; NCOA1; NF B; NRIP1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 140; MICRORNA 22; NUCLEAR RECEPTOR INTERACTING PROTEIN; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION; GENES, REPORTER; HEPATOCYTES; HUMANS; LIVER; LUCIFERASES; MICRORNAS; NF-KAPPA B; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 1; PROMOTER REGIONS, GENETIC;

EID: 80051573524     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.048     Document Type: Article

References (27)

1. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
2. Karin M. Nuclear factor-kappaB in cancer development progression. Nature 2006, 441:431-436.
3. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
4. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 1999, 19:6367-6378.
5. Jin F., Li Y., Ren B., Natarajan R. PU.1 C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc. Natl. Acad. Sci. USA 2011, 108:5290-5295.
6. Na S.Y., Lee S.K., Han S.J., Choi H.S., Im S.Y., Lee J.W. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J. Biol. Chem. 1998, 273:10831-10834.
7. Lee R., Feinbaum R., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
8. Carrington J., Ambros V. Role of microRNAs in plant and animal development. Science 2003, 301:336-338.
9. Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
10. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
11. Lu J., Getz G., Miska E., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B., Mak R., Ferrando A., Downing J., Jacks T., Horvitz H., Golub T. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
12. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. MiR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16:23-29.
13. Kasinski A.L., Slack F.J. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling. Curr. Opin. Mol. Ther. 2010, 12:147-157.
14. Ma X., Becker Buscaglia L.E., Barker J.R., Li Y. MicroRNAs in NF-{kappa}B signaling. J. Mol. Cell. Biol. 2011, 3:159-166.
15. Block T., Mehta A., Fimmel C., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
16. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., Ambs S., Chen Y., Meltzer P., Croce C., Qin L., Man K., Lo C., Lee J., Ng I., Fan J., Tang Z., Sun H., Wang X. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 2009, 361:1437-1447.
17. Krützfeldt J., Rajewsky N., Braich R., Rajeev K., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
18. Miyagawa J., Muguruma M., Aoto H., Suetake I., Nakamura M., Tajima S. Isolation of the novel cDNA of a gene of which expression is induced by a demethylating stimulus. Gene 1999, 240:289-295.
19. Kojima K., Takata A., Vadnais C., Otsuka M., Yoshikawa T., Akanuma M., Kondo Y., Kang Y.J., Kishikawa T., Kato N., Xie Z., Zhang W.J., Yoshida H., Omata M., Nepveu A., Koike K. MicroRNA122 is a key regulator of α-fetoprotein, expression influences the aggressiveness of hepatocellular carcinoma. Nat. Commun. 2011, 2:338.
20. Takata A., Otsuka M., Kogiso T., Kojima K., Yoshikawa T., Tateishi R., Kato N., Shiina S., Yoshida H., Omata M., Koike K. Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines. Hepatol. Int. 2011.
21. Ma L., Weinberg R.A. MicroRNAs in malignant progression. Cell Cycle 2008, 7:570-572.
22. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foà R., Schliwka J., Fuchs U., Novosel A., Müller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
23. Zschiedrich I., Hardeland U., Krones-Herzig A., Berriel Diaz M., Vegiopoulos A., Müggenburg J., Sombroek D., Hofmann T., Zawatzky R., Yu X., Gretz N., Christian M., White R., Parker M., Herzig S. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 2008, 112:264-276.
24. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
25. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA, miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
26. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003, 424:793-796.
27. Iliopoulos D., Jaeger S.A., Hirsch H.A., Bulyk M.L., Struhl K. STAT3 activation of miR-21 and miR-181b-1 via and PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell. 2010, 39:493-506.